Cancer ResearchDepartment of Thoracic Surgery

Our research is funded by the University of Freiburg as well as the German Consortium for Translational Cancer Research (DKTK).

Additional third party funding is available for the following projects:

2022 - 2025
German Research Foundation (DFG)
Mechanisms of nonstop mutations in tumor suppressor genes
(associated with the SFB 1453 NephGen)

2021 - 2023
German Cancer Consortium (Deutsches Konsortium für Translationale Krebsforschung DKTK)
Treatment Prediction and Reverse Translation of the Molecular Tumor Board Freiburg
(jointly with Prof. Dr. Anna-Lena Illert, Dr. Carla Schmidt, Prof. Dr. Tilman Brummer)

2020 - 2023
German Cancer Aid (Deutsche Krebshilfe)
Efficacy, molecular determinants and mechanisms of a combination therapy of ATRA and DNA-hypomethylating agents in lung adenocarcinoma
(together with Prof. Dr. Michael Lübbert)

2021 - 2023
Baden-Württemberg Foundation "International Excellence Program"
RNA at centrosomes and midbodies: Impact of RNA-mediated phase separation during cell division
(Heidelberg, to Dr. Maiwen Caudron-Herger in cooperation with Prof. Dr. Isabelle Vernos, Barcelona)

2020 - 2023
German Cancer Aid (Deutsche Krebshilfe)
RNA-dependent Functions in Mitosis and Cancer
(Heidelberg)

Past Funding:

2021 - 2022
Wilhelm Sander Foundation
RNA Damage Signaling in Response to Therapy: Mechanisms and functions in the cellular response to cytotoxic stress and RNA degradation
(Heidelberg)

2018 - 2021
German Research Foundation (DFG)
Defining the mechanisms of a new class of cancer mutations in the tumor suppressor genes SMAD4, PTEN and CDKN2A